Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 925-928

  Perilli, Mariagrazia ^a   Segatore, Bernardetta ^a   De Massis, Maria Rosaria ^a   Franceschini, Nicola ^a   Bianchi, Ciro ^a   Rossolini, Gian Maria ^a   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; NEW DRUG; PIPERACILLIN; TAZOBACTAM;

AMINO ACID SUBSTITUTION; AMPLICON; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BINDING AFFINITY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVE SITE; HUMAN; ITALY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS;

AZTREONAM; BETA-LACTAMASES; CEPHALOSPORINS; ESCHERICHIA COLI; HUMANS; ITALY; KINETICS; MOLECULAR SEQUENCE DATA; MONOBACTAMS; PROTEUS INFECTIONS; PROTEUS MIRABILIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036172971     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.3.925-928.2002     Document Type: Article

References (21)

1. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-1)
2. Diversity of TEM mutants in Proteus mirabilis
3. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate
4. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum β-lactamases
5. Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases
6. Techniques for transformation of E. coli
7. More extended-spectrum β-lactamases
8. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams
9. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns
10. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
11. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: Mutations, specificity, and three-dimensional structure
12. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae
13. Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain
14. TEM-72, a new extended-spectrum β-lactamase detected in Proteus mirabilis and Morganella morganii in Italy
15. β-Lactamases: Protein evolution in real time
16. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: Epidemiologic studies
17. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322
18. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 β-lactamases from St. Louis, Missouri